Clinical Trials Logo

Filter by:
NCT ID: NCT01003405 Withdrawn - Overactive Bladder Clinical Trials

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Start date: n/a
Phase: Phase 3
Study type: Interventional

To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.

NCT ID: NCT01000896 Withdrawn - Cancer Clinical Trials

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to explore the safety and tolerability of AZD0530 in combination with carboplatin and paclitaxel in Japanese patients with non small cell lung cancer and epithelial ovarian cancer.

NCT ID: NCT00789165 Withdrawn - Arrhythmia Clinical Trials

Empiric Quinidine for Asymptomatic Brugada Syndrome

Start date: December 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if quinidine therapy (not guided by the results of electrophysiologic studies) will reduce the long-term risk of arrhythmic events in asymptomatic Brugada Syndrome.

NCT ID: NCT00511212 Withdrawn - Clinical trials for Postoperative Complications

Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

Start date: August 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy with antibacterial agents for severe peritonitis after lower digestive tract surgery.

NCT ID: NCT00334724 Withdrawn - Hypertension Clinical Trials

Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study

Start date: October 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether blood pressure control by home blood pressure monitoring exerts beneficial cardioprotective effects rather than by clinic blood pressure monitoring in elderly patients.

NCT ID: NCT00304772 Withdrawn - Sepsis Clinical Trials

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

Start date: August 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to verify the equivalence in clinical efficacy of fluconazole and micafungin for the treatment of Candida bloodstream infection in non-neutropenic patients.

NCT ID: NCT00299845 Withdrawn - Clinical trials for Gastroesophageal Reflux

Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children

Start date: n/a
Phase: Phase 4
Study type: Interventional

Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of PPI in children. The results will provide the beneficial information for the individualized medicine of PPI in children.

NCT ID: NCT00247130 Withdrawn - Peptic Ulcers Clinical Trials

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

Start date: October 2005
Phase: Phase 4
Study type: Interventional

The present study will compare the hemostasis-maintaining effects of intravenous omeprazole and ranitidine in patients with upper gastrointestinal hemorrhage that have undergone endoscopic hemostasis, to establish which anti-secretory medication prior to the start of oral alimentation is effective in preventing re-hemorrhage after hemostasis.

NCT ID: NCT00238160 Withdrawn - Clinical trials for Localized Resectable Adult Primary Liver Cancer

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Start date: n/a
Phase: Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving drugs directly into the arteries around the tumor may kill more tumor cells. Giving chemotherapy after surgery may kill any remaining tumor cells. It is not yet known whether surgery and hepatic arterial chemotherapy are more effective than surgery alone in treating patients with liver cancer that has spread to the portal vein. PURPOSE: This randomized phase III trial is studying surgery and hepatic arterial chemotherapy to see how well they work compared to surgery alone in treating patients with liver cancer that has spread to the portal vein.

NCT ID: NCT00209612 Withdrawn - Gastric Cancer Clinical Trials

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

Start date: April 2004
Phase: Phase 1/Phase 2
Study type: Interventional

A phase I/II study is conducted to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and efficacy of a combination chemotherapy using CPT-11 and Paclitaxel in pre-treated patients with metastatic gastric cancer. The usefulness of the this regimen is evaluated by response rate, median survival time, and progression free survival.